[EN] NEURONAL NICOTINIC RECEPTOR AGONISTS FOR TREATING SCHIZOPHRENIA IN PATIENTS WITH VARIANTS OF COMT GENE<br/>[FR] AGONISTES DES RÉCEPTEURS NICOTINIQUES NEURONAUX POUR TRAITER LA SCHIZOPHRÉNIE CHEZ DES PATIENTS PRÉSENTANT DES VARIANTES DU GÈNE COMT
申请人:ABBVIE INC
公开号:WO2013177510A1
公开(公告)日:2013-11-28
This application is directed to α-neuronal nicotinic receptor agonists selective for α7-subtype that are useful for improving cognition impairment in patients having schizophrenia, a schizophreniform disorder or a related schizophrenia spectrum psychotic disorder. Compounds and compositions containing such compounds, and methods of using such compound and compositions are described herein.